Nephrotic Syndrome and Pregnancy: Addressing High-Risk Factors

Factors Placed at High Risk for Pregnant Women with Nephrotic Syndrome

Pregnancy complicated by nephrotic syndrome puts women at high risk of several complications, among the most common of which are the following:

Increased Risk of Thromboembolism

The greatest danger of pregnancy with nephrotic syndrome is thromboembolic events. The woman with nephrotic syndrome is predisposed to a state of developing blood clots more than usual, and pregnancy amplifies this danger. In addition, with NS, there are altered coagulation pathways and immobility caused by edema and other symptoms, which increases the chances of DVT and PE almost exponentially.

Infections

Nephrotic syndrome is one condition where immunocompromised states are common, mainly because of the loss of immunoglobulins in the urine that can predispose to a higher risk of infections. Even more of a concern here is the pregnant woman, as conditions like UTIs or VZV exposure hold potential risks that could jeopardize both the mother and the fetus. Another measure for preventing infection with varicella in pregnant women is the use of an expanded-access program for varicella zoster immune globulin (VARIZIG). Pregnant women are also at high risk for more severe complications of varicella.

Control of Oedema and Blood Pressure

Nephrotic syndrome presents with oedema: this is the swelling that results from fluid accumulation within the body. In pregnancy, oedema worsens; it may lead to complications like reduced mobility, skin breakdown, or even systemic infections. The management of oedema in pregnant women with nephrotic syndrome more often consists of diuretic treatments, though such treatments must be done very carefully as regards the hazardous influence on fetal health. Nephrotic syndrome is mainly accompanied by elevated blood pressure and can easily develop into preeclampsia, a significant condition that may lead to the risks for both mother and child.

Renal Dysfunction

The concerns that most pregnant women with nephrotic syndrome have in mind are renal dysfunction or progression to CKD. Pregnancy, even under normal conditions, strains renal function because the body increases the amount of blood to support the fetus. The presence of nephrotic syndrome could potentially overload the kidneys, impair their ability to carry out the demands of pregnancy, and worsen renal function, potentially resulting in renal failure. Other potential concerns are the balance of blockade of the renin-angiotensin system, which is a mainstay treatment for the patient with nephrotic syndrome, whose effects on fetal development must be carefully weighed.

Preterm Birth and Fetal Growth Restriction

The presence of nephrotic syndrome can also impact the growth and development of the fetus. Women with this condition are more likely to deliver prematurely, increasing risks that are associated with low birth weight, developmental delays, and other neonatal complications. Proteinuria and renal dysfunction would contribute to fetal growth restriction, which is defined as failure of the fetus to achieve the normal expected weight for that gestational age, amplifying the risks in both antenatal and postnatal periods.

Management strategies for Nephrotic Syndrome in pregnancy

Management of nephrotic syndrome in pregnant women involves thorough and multi-dimensional approaches that play between the needs of the mother and those of the baby. Methods to prevent the complications of nephrotic syndrome in pregnant women are mostly medical-mental and integrative through lifestyle change with close follow-up and monitoring.

Thromboprophylaxis

Anticoagulation therapy is very much warranted in pregnant women with nephrotic syndrome, as the latter significantly risks developing thromboembolism. Careful choice, however, is observed when choosing the anticoagulant; usually, low molecular weight heparin rather than warfarin, which can cross the placental barrier, is administered. Thromboprophylaxis needs to be initiated very early, and its response needs to be closely followed in order to avoid complications both on the maternal as well as on the fetal side.

Infection Prevention

Prevention of infections in pregnant women with nephrotic syndrome is highly significant. Immunoglobulin therapy with drugs such as VARIZIG for those exposed to varicella would help avoid risks. Also, vigilance and an eye on early urinary tract infection or other bacterial infections, which might exert an exacerbating influence on the symptoms of nephrotic syndrome during pregnancy, would be crucial.

Control of Blood Pressure

Management of blood pressure is another cornerstone in the treatment algorithm of a pregnant woman with nephrotic syndrome. In fact, preeclampsia and hypertension are very common complications for which close monitoring for maternal and fetal risks is essential. Therefore, antihypertensive agents, like methyldopa or labetalol, are the commonly used drugs of choice for pregnant women. However, due to the risk to the baby, drugs that block the renin-angiotensin system are usually avoided in pregnant patients with nephrotic syndrome.

Fluid and Electrolyte Management

Fluid and electrolyte management in the patient should be taken carefully, as diuretics could be administered not only to help manage oedema but also to prevent dehydration, disturbance of electrolytes, and reductions in perfusion to the placenta. Salt and fluid intake should be controlled as well, not to accelerate oedema and disturbances in blood pressure.

Close Monitoring of Fetal Development

Pregnant women with nephrotic syndrome should be followed up frequently to monitor the development of the baby and early manifestations of distress or growth restriction. Ultrasound scans can help in assessing the size of the fetus and the amniotic fluid index, and Doppler studies may be useful in the assessment of placental blood flow. Once any form of fetal growth restriction or other complications is identified, there might be a predisposition to deliver prematurely.

Multidisciplinary Care

A multidisciplinary team comprising of a nephrologist, obstetrician, and maternal-fetal medicine specialist can help provide a pregnant woman with nephrotic syndrome care that would be holistic. The close coordination among these specialists in managing the case ensures that any mother’s kidney function is followed closely and that pregnancy would be managed towards optimal outcomes. The team will further guide medication adjustment and watch for signs of worsening renal function or preeclampsia.

Conclusion

The complications arising from nephrotic syndrome in pregnancy are a bit specific, and patients with a high risk of thromboembolism, infection, renal dysfunction, and hypertension must be treated. Pregnant women with the disorder must be provided with meticulous management by various pharmacological treatments, changes in the lifestyle, and close follow-up. Healthcare providers can thus make a positive projection by being proactive with regard to both maternal and fetal risks, along with a holistic approach in the care of patients afflicted with nephrotic syndrome.

References

1. Levin, M.J., Duchon, J.M., Swamy, G.K. and Gershon, A.A., 2019. Varicella zoster immune globulin (VARIZIG) administration up to 10 days after varicella exposure in pregnant women, immunocompromised participants, and infants: Varicella outcomes and safety results from a large, open-label, expanded-access program. PloS one, 14(7), p.e0217749.
2. Gupta, S., Pepper, R.J., Ashman, N. and Walsh, S.B., 2019. Nephrotic syndrome: oedema formation and its treatment with diuretics. Frontiers in physiology, 9, p.1868.
3. Weir, M.R., Lakkis, J.I., Jaar, B., Rocco, M.V., Choi, M.J., Kramer, H.J. and Ku, E., 2018. Use of renin-angiotensin system blockade in advanced CKD: an NKF-KDOQI controversies report. American Journal of Kidney Diseases, 72(6), pp.873-884.
4. Lee, J.M., Kronbichler, A., Shin, J.I. and Oh, J., 2020. Review on long‐term non‐renal complications of childhood nephrotic syndrome. Acta Paediatrica, 109(3), pp.460-470.
5. Lentine, K.L., Kasiske, B.L., Levey, A.S., Adams, P.L., Alberú, J., Bakr, M.A., Gallon, L., Garvey, C.A., Guleria, S., Li, P.K.T. and Segev, D.L., 2017. KDIGO clinical practice guideline on the evaluation and care of living kidney donors. Transplantation, 101(8S), pp.S7-S105.